Novozymes A/S (OTCMKTS:NVZMY) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of Novozymes A/S (OTCMKTS:NVZMY) from a strong sell rating to a hold rating in a research note released on Monday morning,Zacks.com reports.

Other equities research analysts have also issued research reports about the stock. Kepler Capital Markets raised shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Rothschild & Co Redburn raised shares of Novozymes A/S to a “strong-buy” rating in a research note on Friday, March 27th. Two research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy”.

Novozymes A/S Price Performance

Shares of Novozymes A/S stock opened at $59.04 on Monday. The firm has a market cap of $24.48 billion, a PE ratio of 39.89, a price-to-earnings-growth ratio of 1.05 and a beta of 0.95. Novozymes A/S has a 12-month low of $49.90 and a 12-month high of $75.99. The company has a quick ratio of 1.03, a current ratio of 1.67 and a debt-to-equity ratio of 0.27. The company’s fifty day simple moving average is $59.38 and its two-hundred day simple moving average is $60.43.

Novozymes A/S (OTCMKTS:NVZMY) last announced its quarterly earnings results on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.31). The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. Novozymes A/S had a return on equity of 6.52% and a net margin of 14.22%. As a group, equities analysts expect that Novozymes A/S will post 2.43 EPS for the current year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).